SOPHIA: A Phase 3, Randomized Study of Margetuximab plus Chemotherapy Vs Trastuzumab plus Chemotherapy in the Treatment of Patients with Her2+Metastatic Breast Cancer
AuthID
P-00M-MSD
P-00M-MSD
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service